| Announce Date | 10/21/2025 |
| EPS Normalized Actual | $3.37 (Beat by $0.32) |
| EPS GAAP Actual | $3.37 (Beat by $0.32) |
| Revenue Actual | $0.632898B |
| Revenue Surprise | Beat by $632.898M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $3.32067 |
| EPS GAAP Estimate | $3.32067 |
| Revenue Estimate | $0.570438673B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 16.94 | 7.49 | 15.92998 | 17.78149 | 2 |
| Dec 2025 | 10.5275 | 12.05 | 9.99015 | 11.09512 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.51 | 0.30661 | 0.632898B | 34.93% | 89.98M |
| FQ2 2025 (Jun 2025) | 2.64 | 2.64 | 1.04058B | 14.75% | 1040.58M |
| FQ1 2025 (Mar 2025) | 1.48 | 1.48 | 0.810308B | 62.28% | 810.31M |
| FQ4 2024 (Dec 2024) | 2.04 | 2.04 | 0.47011B | 23.01% | 470.11M |
| FQ3 2024 (Sep 2024) | 1.36 | 1.36 | 0.411834B | 18.4% | 411.83M |
| FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 0.88709B | 62.06% | 887.09M |
| FQ1 2024 (Mar 2024) | 0.78 | 0.78 | 0.30566B | -119.55% | 305.66M |
| FQ4 2023 (Dec 2023) | -0.74 | -0.74 | 0.361939B | 69.96% | 361.94M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
3.32067
Consensus Revenue Estimates
0.570438673B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.35173 | -- | 4.20884 | 4.48789 | 2 |
| FQ3 2027 (Sep 2027) | 4.79732 | -- | 4.6283 | 4.95972 | 1 |
| FQ2 2027 (Jun 2027) | 4.6044 | -- | 4.44217 | 4.76027 | 1 |
| FQ1 2027 (Mar 2027) | 4.09777 | -- | 3.86395 | 4.35593 | 1 |
| FQ4 2026 (Oct 2026) | 3.97401 | -- | 3.6248 | 4.3461 | 3 |
| FQ3 2026 (Jul 2026) | 3.78598 | 7.29 | 3.45329 | 4.14047 | 4 |
| FQ2 2026 (Jun 2026) | 3.1822 | 17.04 | 2.9545 | 3.4182 | 4 |
| FQ1 2026 (Mar 2026) | 2.6138 | 43.38 | 2.42677 | 2.80765 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.71B | -- | 0.69B | 0.73B | 2 |
| FQ3 2027 (Sep 2027) | 0.72B | -- | 0.7B | 0.74B | 2 |
| FQ2 2027 (Jun 2027) | 0.71B | -- | 0.69B | 0.73B | 2 |
| FQ1 2027 (Mar 2027) | 0.65B | -- | 0.62B | 0.68B | 2 |
| FQ4 2026 (Oct 2026) | 0.62B | -- | 0.58B | 0.67B | 2 |
| FQ3 2026 (Jul 2026) | 0.6B | -5.1 | 0.56B | 0.65B | 2 |
| FQ2 2026 (Jun 2026) | 0.55B | -89.63 | 0.52B | 0.58B | 2 |
| FQ1 2026 (Mar 2026) | 0.5B | -62.54 | 0.47B | 0.53B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.20339 | 3.51 | 0.30661 | 8.74% |
| FQ2 2025 (Jun 2025) | 2.64 | 2.64 | 100% | |
| FQ1 2025 (Mar 2025) | 1.48 | 1.48 | 100% | |
| FQ4 2024 (Dec 2024) | 2.04 | 2.04 | 100% | |
| FQ3 2024 (Sep 2024) | 1.36 | 1.36 | 100% | |
| FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 100% | |
| FQ1 2024 (Mar 2024) | 0.78 | 0.78 | 100% | |
| FQ4 2023 (Dec 2023) | -0.74 | -0.74 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.54B | $0.63B | $89.98M | 14.22% |
| FQ2 2025 (Jun 2025) | $0B | $1.04B | $1040.58M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.81B | $810.31M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.47B | $470.11M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.41B | $411.83M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.89B | $887.09M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.31B | $305.66M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.36B | $361.94M | 100% |